1Pindzola JA,Kovatich AJ,Bibbo M.p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma[].Acta Cytologica.2000
同被引文献21
1Queiroz C, Barral-Netto M, Bacchi CE. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry. Acta Cytol, 2001, 45:18-22.
2Dejmek A, Hjerpe A. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis. Cytopathology, 2000, 11:8-17.
3Festch PA, Abati A. Immunocytochemistry in effusion cytology: a contemporary review. Cancer,2001,93:293-308.
4Fetsch PA, Simsir A, Brosky K, et al. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry. Diagn Cytopathol, 2002, 26: 61-66.
5Yun G,Xiaoping S,Claire WM,et al. Immunocytochemistry of serous effusion specimens:a comparison of ThinPrep vs. cell block. Diagn Cytopathol, 2003,28:1-5.
6Maria DL, Angel P, Gemma RT, et al. Immunocytochemistry in the differential diagnosis of serous effusions. A comparative evaluation of eight monoclonal antibodies in Papaniclaou stained smears. Cancer,2001,93: 68-72.
7Grove A, Paulsen SM, Gregersen M. The value of immuno-histochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma. Pathol Res Pract, 1990, 190:1044-1055.
8Nagel H, Bernhard H, Ilka R, et al. The value of anti-Calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology. Pathol Res Pract, 1998, 194:759-764.
9Habashi A, Morsi B, Freeman SM, et al. Tumor oncogenic expression in malignant effusions as a possible method to enhance cytologic diagnostic sensitivity. An immunocytochemical study of 87 cases. Am J Clin Pathol, 1995, 103: 206-214.
10Cheepsumon S, Leong AS, Vinyuvat S. Immunostaining of cells preparations: a comparative evaluation of common fixatives and protocols. Diagn Cytopathol, 1996, 15: 167-174.
